Efficacy of Autologous Platelet-Rich Plasma Combined With a Non-Cross-Linked Hyaluronic Acid Compound in the Treatment of Female Androgenetic Alopecia: A Retrospective, Case-Series Study

    Shiwei Wang, Dongmei Li, Muyan Zou, Jiaxu Wu, Xuehan Wang, Yu Yang, Xin Li, Wei Yang
    Image of study
    TLDR The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.
    The retrospective, case-series study involved 9 female patients with androgenetic alopecia (FAGA) and evaluated the efficacy of a treatment combining autologous platelet-rich plasma (PRP) and a non-cross-linked hyaluronic acid (HA) compound. The treatment led to a significant improvement in hair density and reduction in areas of alopecia, with a 54.51% increase in hair count at 1 month and a 77.25% increase at 3 months. The treatment's clinical efficacy could last beyond 3 months, and patients reported high satisfaction levels. Mild side effects occurred but resolved within 72 hours, and no serious adverse events occurred, indicating the treatment is safe and well-tolerated. The study concluded that the combination of PRP and non-cross-linked HA compound is effective and safe in treating FAGA, but further randomized controlled trials with larger sample sizes are needed to confirm these findings.
    Discuss this study in the Community →

    Research cited in this study

    13 / 13 results

    Related Community Posts Join

    6 / 79 results

    Related Research

    6 / 6 results